Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 48 weeks.
Saved in:
| Title: | Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 48 weeks. |
|---|---|
| Authors: | Pérez-Stachowski J; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain., Tortajada B; b Department of Pharmacy, Hospital Costa del Sol , Marbella , Spain., Del Arco A; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain., Márquez E; b Department of Pharmacy, Hospital Costa del Sol , Marbella , Spain., De la Torre J; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain., Nieto M; b Department of Pharmacy, Hospital Costa del Sol , Marbella , Spain., García de Lomas JM; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain., Prada JL; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain., García-Alegría J; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain., Olalla J; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain. |
| Source: | Infectious diseases (London, England) [Infect Dis (Lond)] 2019 Sep; Vol. 51 (9), pp. 691-693. Date of Electronic Publication: 2019 Jul 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 101650235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2374-4243 (Electronic) Linking ISSN: 23744243 NLM ISO Abbreviation: Infect Dis (Lond) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2374-4243 |
|---|---|
| DOI: | 10.1080/23744235.2019.1637536 |
